Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04515992 · ClinicalTrials.gov registry record · NA
High Intensity Body-weight Circuit Training in Type 2 Diabetics
A NA study, sponsored by Kennesaw State University.
- Completed
- Registry status
- NA
- Development phase
- 6
- Enrollment target
NCT04515992 is a NA study that has completed, run by Kennesaw State University. The registered enrollment target is 6 participants.
The verdict
NCT04515992, a NA study, has completed, sponsored by Kennesaw State University.
- COMPLETED
- Registry status
- NA
- Development phase
- 6 participants
- Enrollment target
Study Summary
Exercise has been shown to be effective at improving fitness, as well as markers of glucose tolerance and control, in persons with type 2 diabetes. Recently, several investigations have demonstrated that improvements are realized by patients with high intensity interval exercise which is characterized by periods of vigorous exercise alternated by periods of moderate exercise. Typical interval training sessions require significantly less time to complete than traditional modes of exercise wherein moderate intensity activity is sustained for some time. This may be especially beneficial to those with type 2 diabetes, as lack of time is a frequently cited reason for not engaging in regular exercise. Bodyweight circuit training carries the potential to similarly improve health and metabolic function in persons with type 2 diabetes, and may do so with even a smaller accumulation of exercise because this type of exercise involves a greater percentage of the trainee's muscle mass compared with common forms of interval training (e.g., treadmill or cycle exercise). The purpose of this study is to quantify the effects of 3-4 sessions per week of bodyweight circuit training sustained for 5-10 minutes per session on health-related physical fitness and glucose tolerance/control in people with type 2 diabetes.
Interventions
- BEHAVIORAL High Intensity Body-weight Circuit Training (HIBC)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 6 participants |
| Start Date | 2018-03-01 |
| Est. Completion | 2018-09-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04515992
The ClinicalTrials.gov registry entry for NCT04515992 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 6 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Kennesaw State University, which has 8 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which High Intensity Body-weight Circuit Training (HIBC) is the first listed.
NCT04515992 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04515992 about?
NCT04515992 is a clinical study titled "High Intensity Body-weight Circuit Training in Type 2 Diabetics". Exercise has been shown to be effective at improving fitness, as well as markers of glucose tolerance and control, in persons with type 2 diabetes. Recently, several investigations have demonstrated that improvements are realized by patients with high intensity interval exercise which is characteriz...
What is the current status of trial NCT04515992?
This trial is currently completed. It is a NA study. The enrollment target is 6 participants. The study started on 2018-03-01. Estimated completion is 2018-09-01.
What interventions are being tested in trial NCT04515992?
The interventions under investigation include: High Intensity Body-weight Circuit Training (HIBC) (BEHAVIORAL).
Who is sponsoring clinical trial NCT04515992?
This trial is sponsored by Kennesaw State University, which has 8 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.